Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer

Autor:	S. Cheporov, A. Koryakova, V. Azarova, S. Baranovsky, Andrew Cakana, O. Karavaeva, Georgy M. Manikhas, Mikhail Fedyanin, V. Vladimirov, Sergey Orlov, Sergei Tjulandin, V. Moiseenko, C. Phelps, N. Vostokova
Rok vydání:	2017
Předmět:	Cisplatin Oncology Cancer Research medicine.medical_specialty business.industry Quisinostat non-small cell lung cancer (NSCLC) medicine.disease Gemcitabine Carboplatin chemistry.chemical_compound chemistry Paclitaxel Pharmacokinetics Internal medicine medicine In patient business medicine.drug
Zdroj:	European Journal of Cancer. 72:S96
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::f71da0ff72c093f727958f9528e7a1ac https://doi.org/10.1016/s0959-8049(17)30397-0 Zobrazit plný text záznamu Full Text from ScienceDirect